Updated 08:09 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,859.70 -0.68% CL 88.67 +0.12% BTC 64,634.95 -1.03%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,860 −0.68% BTC $64,635 −1.03% VIX 19.30 +3.21% latest tape · as of 08:09 UTC
The Screen · Financials · Financial Data & Stock Exchanges

Deutsche Boerse AG

DB1.DE · XETRA · EUR · Market cap $45.4B · 15,433 employees

Deutsche Börse AG operates as an international exchange organization in Germany, rest of Europe, the United States, and the Asia-Pacific.

FAIL · Does not pass the screen
330.40 EUR

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 08:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price330.40 EUR at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: 216.00 EUR to 285.27 EUR, base estimate 248.06 EUR (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price330.40 EUR
Fair value248.06
Ethical score30.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Markup279.90+18.0% to today ✓Distribution gives way to Markup first Markup read since July
2026-10-02Read Distribution279.90+18.0% to today Accumulation gives way to Distribution after a 12% rise in 5 weeks
2026-08-26Read Accumulation249.50+32.4% to today ✓Markup gives way to Accumulation
2026-07-26Read Markup249.50+32.4% to today ✓Distribution gives way to Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Deutsche Boerse AG holds its Markup at $330.40. Consolidating, no directional conviction, held for 24 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 24 days
Price at the screen$330.40
Valuation24.92 trailing · 21.03 forward price to earnings
Values screenFAIL · score 30.0
Beta0.28
The Workings

Five Screens, Shown in Full

Does not pass. Business activity exclusion: likely FAIL

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Business activity exclusion: likely FAIL Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Deutsche Boerse does not clear the screen at the business-activity stage. It operates in an area the screen excludes: Business activity exclusion: likely FAIL, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when DB1.DE's ethical verdict changes

Today DB1.DE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 248.06 EUR fair value estimate, 8.50% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

216.00Conservative248.06Base case285.27Growth case 330.40Price

Fair value range in EUR, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 33.2% above the base estimate.

The Street's Range
240.00Street low 296.50Street average 310.00Street high 330.40Price

Third-party analyst targets: 12 covering, consensus Buy. The average target sits −10% from the screen price.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate 248.06 EUR, with a range of 216.00 EUR to 285.27 EUR, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 21.0x forward earnings, the price already runs ahead of the business. It trades 33% above our 248.06 EUR fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E21.0xexpensive even after accounting for its growth
Trailing P/E24.9xa premium valuation
EPS, trailing11.23
EPS, forward13.31
Revenue growth+8.5%steady growth
Profit margin27.3%healthy profit margins
Return on equity19.2%a solid return on shareholder capital
Dividend yield1.64%
Debt to equity0.65moderate, manageable leverage
Beta0.28barely tracks the market's swings
52-week range200.10 - 279.10
Market cap$45.4B
Employees15,433

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to Germany and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

DB1.DE trades on XETRA (the company is based in Germany). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-06 Markup $318.70 +13.9% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 31% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-10-26 Markup · changed $279.90 +0.0% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 31% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-10-15 Distribution $279.90 +0.0% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-10-02 Distribution · changed $279.90 +12.2% Entry 6

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 12.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-08-26 Accumulation · changed $249.50 +0.0% Entry 5

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-07-26 Markup · changed $249.50 +0.0% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-07-18 Distribution $249.50 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (13 analysts) rates it buy, with a mean price target of $288.

2026-07-03 Distribution $249.50 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Distribution $249.50 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $243.75 +1.3% $4.20 $1,030 +3.0%
2 months $248.17 -0.6% $4.20 $1,011 +1.1%
3 months $232.35 +6.2% $4.20 $1,080 +8.0%
6 months $211.42 +16.7% $4.20 $1,187 +18.7%
1 year $273.14 -9.6% $4.20 $919 -8.1%
2 years $180.31 +36.9% $8.20 $1,414 +41.4%
3 years $156.31 +57.9% $12.00 $1,656 +65.6%
5 years $122.78 +101.0% $18.80 $2,163 +116.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DB1.DE does next, these words stay.

Deutsche Boerse AG · DB1.DE · Markup · $330.40
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.